Stock comparison
Royalty Pharma
RPRX$32.69BHealthcare Market cap, Sector
SANOFI CONS HEALTHC IND L
SANOFICONR.NS$104.11BHealthcare Market cap, Sector
Overall winner
SANOFI CONS HEALTHC IND L
RPRX 07 SANOFICONR.NS
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
RPRX0wins
7winsSANOFICONR.NS
64C
B78
82B
A89
63C
B83
58D
B77
38F
A91
66C
A86
56D
A85
Side-by-side metrics
| Metric | RPRX | SANOFICONR.NS |
|---|---|---|
| Market cap | $32.69B | $104.11B Winner |
| P/E (TTM) | Winner: 27.6x | 44.2x |
| EV/EBIT | Winner: 19.9x | 31.8x |
| ROIC (TTM) | 8.43% | 59.15% Winner |
| Gross margin | Winner: 99.95% | 68.13% |
| Net margin | Winner: 33.91% | 27.35% |
| Revenue CAGR 5y | 0.96% | 27.01% Winner |
| EPS CAGR 5y | 11.83% | 20.67% Winner |
| Debt / Equity | 1.3x | 0.1x Winner |
| Dividend yield | 1.72% | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
RPRX leads on
- P/E (TTM)27.6xvs 44.2x+38%
- EV/EBIT19.9xvs 31.8x+37%
- Gross margin99.95%vs 68.13%+32%
- Net margin33.91%vs 27.35%+19%
SANOFICONR.NS leads on
- Revenue CAGR 5y27.01%vs 0.96%+96%
- Debt / Equity0.1xvs 1.3x+95%
- ROIC (TTM)59.15%vs 8.43%+86%
- Market cap$104.11Bvs $32.69B+69%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.